Cytokinetics | CYTK - Stock



Cytokinetics reported 0 in Stock for its fiscal quarter ending in December of 2023.


Stock Change Date
Acadia Pharmaceuticals USD 26.12M 3.18M Jun/2025
Amgen USD 6.58B 146M Jun/2025
Bayer EUR 12.11B 576M Jun/2025
Biogen USD 2.27B 400K Jun/2025
Bristol-Myers Squibb USD 2.74B 71M Jun/2025
Cytokinetics 0 0 Dec/2023
Eisai JPY 227.32B 11.41B Jun/2025
Eli Lilly USD 11.01B 1.7B Jun/2025
Exelixis USD 23.48M 1.37M Jun/2025
Geron USD 69.12M 12.9M Jun/2025
Halozyme Therapeutics USD 181.5M 16.64M Jun/2025
Ionis Pharmaceuticals USD 8.48M 3.02M Jun/2025
Ligand Pharmaceuticals USD 15.49M 875K Jun/2025
Merck USD 6.6B 405M Jun/2025
Novartis USD 6.31B 478M Jun/2025
Pfizer USD 11.67B 817M Jun/2025
Regeneron Pharmaceuticals USD 3.21B 760.7M Jun/2025
Roche Holding CHF 7.61B 339M Dec/2024
Sanofi EUR 9.62B 12.23B Jun/2025